JP2018535261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018535261A5 JP2018535261A5 JP2018545102A JP2018545102A JP2018535261A5 JP 2018535261 A5 JP2018535261 A5 JP 2018535261A5 JP 2018545102 A JP2018545102 A JP 2018545102A JP 2018545102 A JP2018545102 A JP 2018545102A JP 2018535261 A5 JP2018535261 A5 JP 2018535261A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkylene
- heteroaryl
- pharmaceutically acceptable
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021131351A JP7174963B2 (ja) | 2015-11-13 | 2021-08-11 | 疾患の処置のための複素環化合物 |
| JP2022173717A JP7445325B2 (ja) | 2015-11-13 | 2022-10-28 | 疾患の処置のための複素環化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562255041P | 2015-11-13 | 2015-11-13 | |
| US62/255,041 | 2015-11-13 | ||
| PCT/US2016/061676 WO2017083756A1 (en) | 2015-11-13 | 2016-11-11 | Heterocyclic compounds for the treatment of disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021131351A Division JP7174963B2 (ja) | 2015-11-13 | 2021-08-11 | 疾患の処置のための複素環化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018535261A JP2018535261A (ja) | 2018-11-29 |
| JP2018535261A5 true JP2018535261A5 (enExample) | 2019-12-19 |
| JP6933384B2 JP6933384B2 (ja) | 2021-09-08 |
Family
ID=58696139
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018545102A Active JP6933384B2 (ja) | 2015-11-13 | 2016-11-11 | 疾患の処置のための複素環化合物 |
| JP2021131351A Active JP7174963B2 (ja) | 2015-11-13 | 2021-08-11 | 疾患の処置のための複素環化合物 |
| JP2022173717A Active JP7445325B2 (ja) | 2015-11-13 | 2022-10-28 | 疾患の処置のための複素環化合物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021131351A Active JP7174963B2 (ja) | 2015-11-13 | 2021-08-11 | 疾患の処置のための複素環化合物 |
| JP2022173717A Active JP7445325B2 (ja) | 2015-11-13 | 2022-10-28 | 疾患の処置のための複素環化合物 |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US10683291B2 (enExample) |
| EP (2) | EP3373931B1 (enExample) |
| JP (3) | JP6933384B2 (enExample) |
| KR (1) | KR102720397B1 (enExample) |
| CN (2) | CN108463222B (enExample) |
| AU (2) | AU2016353348A1 (enExample) |
| BR (1) | BR112018009745B1 (enExample) |
| CA (1) | CA3005236C (enExample) |
| DK (1) | DK3373931T3 (enExample) |
| ES (1) | ES2932049T3 (enExample) |
| HR (1) | HRP20221417T1 (enExample) |
| HU (1) | HUE060594T2 (enExample) |
| IL (1) | IL259297B2 (enExample) |
| LT (1) | LT3373931T (enExample) |
| MX (1) | MX382092B (enExample) |
| PL (1) | PL3373931T3 (enExample) |
| PT (1) | PT3373931T (enExample) |
| RS (1) | RS63837B1 (enExample) |
| RU (1) | RU2727194C2 (enExample) |
| SI (1) | SI3373931T1 (enExample) |
| SM (1) | SMT202300062T1 (enExample) |
| WO (1) | WO2017083756A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6933384B2 (ja) | 2015-11-13 | 2021-09-08 | オピラン ファーマ エルティーディー． | 疾患の処置のための複素環化合物 |
| WO2018211323A1 (en) * | 2017-05-17 | 2018-11-22 | Oppilan Pharma Ltd. | Hetercyclic compounds for the treatment of disease |
| EP3625230A1 (en) * | 2017-05-17 | 2020-03-25 | Oppilan Pharma Ltd. | Prodrugs for the treatment of disease |
| GB201815018D0 (en) * | 2018-09-14 | 2018-10-31 | Univ Oxford Innovation Ltd | Enantiomeric compounds |
| WO2024011142A1 (en) * | 2022-07-06 | 2024-01-11 | Oppilan Pharma Limited | Crystalline forms of an s1p receptor modulator |
| EP4649080A1 (en) * | 2023-01-13 | 2025-11-19 | Oppilan Pharma Ltd. | Preparation of an s1p receptor modulator |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772597A (en) * | 1983-10-14 | 1988-09-20 | Pfizer Inc. | 2-azacycloalkylthiopenem derivatives |
| AU2004277947A1 (en) * | 2003-10-01 | 2005-04-14 | Merck & Co., Inc. | 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as S1P receptor agonists |
| GB0511684D0 (en) * | 2005-06-08 | 2005-07-13 | Novartis Ag | Organic compounds |
| BRPI0612028A2 (pt) * | 2005-06-08 | 2010-10-13 | Novartis Ag | oxadiazóis ou isodiazóis policìclicos e uso dos mesmos como ligantes de receptor s1p |
| RU2425832C2 (ru) * | 2006-04-03 | 2011-08-10 | Астеллас Фарма Инк. | Гетеросоединение |
| US20110207704A1 (en) | 2006-12-15 | 2011-08-25 | Abbott Laboratories | Novel Oxadiazole Compounds |
| RU2009127095A (ru) | 2006-12-15 | 2011-01-20 | Эбботт Лэборетриз (Us) | Новые оксадиазольные соединения |
| US20100160369A1 (en) * | 2008-12-04 | 2010-06-24 | Exelixis, Inc. | S1P1 Agonists and Methods of Making And Using |
| WO2010117662A1 (en) | 2009-03-30 | 2010-10-14 | Exelixis, Inc. | Modulators of s1p and methods of making and using |
| US9011494B2 (en) | 2009-09-24 | 2015-04-21 | Warsaw Orthopedic, Inc. | Composite vertebral rod system and methods of use |
| MY160907A (en) | 2009-11-13 | 2017-03-31 | Receptos Inc | Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| WO2012012477A1 (en) * | 2010-07-20 | 2012-01-26 | Bristol-Myers Squibb Company | Substituted 3-phenyl-1,2,4-oxadiazole compounds |
| KR20140077965A (ko) | 2011-10-20 | 2014-06-24 | 글락소스미스클라인 엘엘씨 | 시르투인 조절제로서의 치환된 비시클릭 아자-헤테로사이클 및 유사체 |
| CN105793238B (zh) | 2013-11-27 | 2019-12-24 | 基因泰克公司 | 经取代的苯甲酰胺及其使用方法 |
| JP6933384B2 (ja) | 2015-11-13 | 2021-09-08 | オピラン ファーマ エルティーディー． | 疾患の処置のための複素環化合物 |
-
2016
- 2016-11-11 JP JP2018545102A patent/JP6933384B2/ja active Active
- 2016-11-11 SM SM20230062T patent/SMT202300062T1/it unknown
- 2016-11-11 PT PT168651560T patent/PT3373931T/pt unknown
- 2016-11-11 KR KR1020187016508A patent/KR102720397B1/ko active Active
- 2016-11-11 EP EP16865156.0A patent/EP3373931B1/en active Active
- 2016-11-11 DK DK16865156.0T patent/DK3373931T3/da active
- 2016-11-11 SI SI201631650T patent/SI3373931T1/sl unknown
- 2016-11-11 CN CN201680078856.8A patent/CN108463222B/zh active Active
- 2016-11-11 IL IL259297A patent/IL259297B2/en unknown
- 2016-11-11 HR HRP20221417TT patent/HRP20221417T1/hr unknown
- 2016-11-11 MX MX2018005987A patent/MX382092B/es unknown
- 2016-11-11 BR BR112018009745-4A patent/BR112018009745B1/pt active IP Right Grant
- 2016-11-11 RS RS20221070A patent/RS63837B1/sr unknown
- 2016-11-11 CN CN202111183182.7A patent/CN114149424B/zh active Active
- 2016-11-11 US US15/775,723 patent/US10683291B2/en active Active
- 2016-11-11 LT LTEPPCT/US2016/061676T patent/LT3373931T/lt unknown
- 2016-11-11 ES ES16865156T patent/ES2932049T3/es active Active
- 2016-11-11 AU AU2016353348A patent/AU2016353348A1/en not_active Abandoned
- 2016-11-11 RU RU2018121416A patent/RU2727194C2/ru active
- 2016-11-11 WO PCT/US2016/061676 patent/WO2017083756A1/en not_active Ceased
- 2016-11-11 CA CA3005236A patent/CA3005236C/en active Active
- 2016-11-11 EP EP22195151.0A patent/EP4163281A1/en active Pending
- 2016-11-11 HU HUE16865156A patent/HUE060594T2/hu unknown
- 2016-11-11 PL PL16865156.0T patent/PL3373931T3/pl unknown
-
2020
- 2020-05-01 US US16/865,212 patent/US20200325135A1/en not_active Abandoned
-
2021
- 2021-05-10 AU AU2021202945A patent/AU2021202945B2/en active Active
- 2021-08-11 JP JP2021131351A patent/JP7174963B2/ja active Active
-
2022
- 2022-03-18 US US17/698,991 patent/US20220227767A1/en not_active Abandoned
- 2022-10-28 JP JP2022173717A patent/JP7445325B2/ja active Active
-
2023
- 2023-06-29 US US18/344,594 patent/US20230339944A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018535261A5 (enExample) | ||
| JP2017535614A5 (enExample) | ||
| JP2018529650A5 (enExample) | ||
| JP2015024998A5 (enExample) | ||
| RU2017121588A (ru) | Конденсированные бициклические соединения для лечения заболевания | |
| JP2020530487A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2019501130A5 (enExample) | ||
| JP2017105793A5 (enExample) | ||
| JP2017523225A5 (enExample) | ||
| JP2019518766A5 (enExample) | ||
| JP2020510091A5 (enExample) | ||
| RU2019116512A (ru) | Ингибиторы magl | |
| JP2014503574A5 (enExample) | ||
| JP2016518434A5 (enExample) | ||
| RU2016118768A (ru) | Композиции, пригодные для лечения расстройств, связанных с kit | |
| JP2018528261A5 (enExample) | ||
| JP2016121196A5 (enExample) | ||
| RU2019115784A (ru) | Ингибиторы magl | |
| RU2019116514A (ru) | Ингибиторы magl | |
| JP2012526728A5 (enExample) | ||
| JP2018504437A5 (enExample) | ||
| JP2010539095A5 (enExample) | ||
| HRP20161478T1 (hr) | Inhibitori protein kinaze (varijante), njihova upotreba za liječenje neuroloških bolesti, kao i farmaceutski pripravak koji se na njima temelji | |
| JP2017538773A5 (enExample) |